General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
Yung AR, Phillips LJ, McGorry PD, McFarlane CA, Francey S, Harrigan S, Patton GC, and Jackson HJ (1998).
British Journal of Psychiatry (Supplement) 172 (Suppl 33): 14-20.
IMPORTANCE FOR EARLY INTERVENTION
Although there were only a small number of at-risk individuals in this sample, 40% of them made the transition from being at-risk for psychosis to being psychotic within a six month followup period. This high rate raises the question of whether specific early interventionsincluding antipsychotic medications and psychosocial interventionshould be targeted at individuals showing these at-risk symptoms, especially if their baseline testing scores indicate them to be particularly vulnerable. The fact that five of the eight individuals who became psychotic in this sample did so within the first month of followup further suggests that this period is one of particularly high risk. At the least, close followup of identified vulnerable individuals could minimize the duration of untreated psychosis, hence improving outcome for these individuals.
SUMMARY
It has long been acknowledged that people who become psychotic often experience some changes in behavior in the period preceding the onset of psychosis; this period has been known as the prodrome. The goal of this study was to identify individuals experiencing prodromal symptoms and thus likely to become psychotic within a followup period, with the eventual goal of either preventing full-blown psychosis or minimizing their symptoms and disability.
The study recruited individuals with psychological features which seemed to indicate the presence of a prepsychotic symptoms, e.g., individuals at risk for psychosis. Individuals were recruited if they showed either "attenuated" or "transient" psychotic symptoms. The former was defined as the presence of ideas of reference, odd beliefs or magical thinking, perceptual disturbance, odd thinking and speech, paranoid ideation, or odd behavior or appearance, apparent for at least a week. "Transient" psychotic symptoms were identified in individuals who had already experienced psychotic symptomshallucinations, delusions, unusual thought content, suspiciousness or formal thought disorderbut whose symptoms had lasted less than a week and resolved spontaneously. In addition, the authors considered individuals who had a family history of a first-degree relative with a psychotic disorder, as well as individuals with schizotypal personality disorder as being at-risk for developing psychosis.
The authors hypothesized that the rate of transition to psychosis would be 20-30% of the cases over a 12-month period, and that people who became psychotic would display more aberrant results on testing measures than people who did not; furthermore, they did not expect the two groups to differ on baseline measures. In order to assess psychopathology, the authors administered the Brief Psychiatric Rating Scale (BPRS), the Scale for the Assessment of Negative Symptoms (SANS), the Hamilton Rating Scale for Depression (HRSD), and the mania rating scale. When admitted to the program, individuals also received the Quality of Life (QLS) scale and the Global Assessment of Functioning (GAF), both of which measure functioning and disability. All of these tests were administered before the development of frank psychosis.
The sample consisted of the first 20 people recruited into
the study, who were followed for six months. At the end of the six months, eight
individuals (40%) had become psychoticfive within the first month of followup, one
between months three and four, and two between months five and six. This suggests that the
first month after seeking help is a period of particularly high risk for at-risk
individuals. Significantly, differences were found on baseline scores for the BPRS, HRSD,
and GAF between the eight individuals who became psychotic and the 12 who did not. This
suggests that testing measures that assess psychopathology and functioning can actually
distinguish between individuals likely to become psychotic within a six-month period and
individuals who are simply at-risk for psychosis.
General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
The contents of all material available on the Center's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made to the Treatment Advocacy Center. Please feel free to call with questions on mental illness, treatment laws or the benefits of medication compliance at 703.294.6001 or send questions via email to [email protected]. Write to us at: The Treatment Advocacy Center; 3300 N. Fairfax Drive; Suite 220; Arlington, VA 22201. Technical comments on the Center's website (www.psychlaws.org) can be sent to [email protected]. The Treatment Advocacy Center is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. |